Intuitive Surgical, Inc. $ISRG Shares Sold by PFG Investments LLC

PFG Investments LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,581 shares of the medical equipment provider’s stock after selling 217 shares during the period. PFG Investments LLC’s holdings in Intuitive Surgical were worth $2,489,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Norway Savings Bank boosted its stake in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after acquiring an additional 910 shares during the period. IronOak Wealth LLC. acquired a new position in Intuitive Surgical in the second quarter valued at approximately $1,099,000. Trust Co. of Oklahoma acquired a new position in Intuitive Surgical in the second quarter valued at approximately $363,000. Neville Rodie & Shaw Inc. boosted its stake in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares during the period. Finally, Compagnie Lombard Odier SCmA boosted its stake in Intuitive Surgical by 633.9% in the second quarter. Compagnie Lombard Odier SCmA now owns 33,311 shares of the medical equipment provider’s stock valued at $18,102,000 after acquiring an additional 28,772 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 2.1%

Shares of NASDAQ:ISRG opened at $438.04 on Thursday. The company’s fifty day moving average is $465.33 and its two-hundred day moving average is $500.54. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a market cap of $157.03 billion, a P/E ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the business earned $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock valued at $21,716,492 in the last three months. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ISRG shares. BTIG Research restated a “buy” rating and issued a $571.00 target price on shares of Intuitive Surgical in a research note on Wednesday. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, Piper Sandler reiterated an “overweight” rating and set a $595.00 price objective (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $594.19.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.